Pharmacy

Industry insiders believe that the Anthem lawsuit against Express Scripts over drug pricing may provide some clues into this complex situation.

An in-depth look at the effects of PDMPs, which are electronic databases used to track the prescribing and dispensing of controlled prescription drugs to patients.

While the high cost of specialty pharmacy is no surprise in the healthcare industry, infusibles have additional challenges. Here are the challenges that top the list, and what to do about them.

PBM Express Scripts shares findings from its new Drug Trend Report.

Prior authorizations are here to stay. Are yours working against you? Find out.

Model set to improve compliance, reduce costs, but reimbursement challenges remain.

Factors include rising costs of brand medications, increased specialty therapy use

New research suggests that mail-order pharmacies may help stroke survivors take their meds.

Analysis finds scientific validation of personalized medicine’s ability to improve patient outcomes.

: Proactive pharma tools help CVS manage pharmacy costs and focus on ensuring patients have access to the right drugs at the lowest cost.

Patients with chronic diseases who received a home visit in HealthPartners’ pilot MTM program reduced readmissions within the first year. Find out how.

PhRMA ad campaign features new patient and researcher stories.

PBMs, insurers use cautious approach when managing these cholesterol-lowering drugs.

Drug price increases can prove challenging for payers. Here’s six strategies to keep in your arsenal.

How at-risk negotiations with pharmaceutical manufacturers and medication adherence programs improve both sides of the healthcare value equation: patient outcomes and costs.

Opioids are powerful clinical tools that effectively treat pain and have a place in therapy, but it can be difficult to manage the dangers. Here's a look at some of the abuse-deterrent drugs on the horizon.

Prime Therapeutics has studied the costs and clinical events relationship among their members using a controlled substances (CS) score algorithm that identifies potential overuse/abuse of opioids/controlled substances.

A new survey reveals what employers' medical plans are doing to rein in specialty drug cost and utilization.

New research: Hospitals risk millions from failure to provide consumer-friendly mobile apps. How to achieve exceptional consumer experience.

New initiative poised to be a model for health plan providers to foster improved collaboration between pharmacists and physicians.

Payers weigh the benefits of using their own resources to develop a specialty pharmacy or contracting outside for services.

There's good news in efforts to combat HIV/AIDs and hepatitis C (hep C, HCV). Some feel, however, that policymakers could do more to prioritize resources to fully eradicate the diseases.

The Association for Community Affiliated Plans recently convened 13 plans to take on together the issue of prescription drug abuse.

Four new drugs and a biosimilar should be on your radar.

When it comes to managing rheumatoid arthritis drugs, cost comes in various sizes and shapes.